18 related articles for article (PubMed ID: 22931421)
1. Synthetically modified methoxsalen for enhanced cytotoxicity in light and dark reactions.
Guillon CD; Jan YH; Foster N; Ressner J; Heck DE; Laskin JD; Heindel ND
Bioorg Med Chem Lett; 2019 Feb; 29(4):619-622. PubMed ID: 30638875
[TBL] [Abstract][Full Text] [Related]
2. Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line.
Wagner MS; Schultze E; Oliveira TL; de Leon PMM; Thurow HS; Campos VF; Oliveira I; de Souza D; Rodrigues OED; Collares T; Seixas FK
Front Oncol; 2018; 8():525. PubMed ID: 30524958
[TBL] [Abstract][Full Text] [Related]
3. Proteome Analysis of Human Follicular Thyroid Cancer Cells Exposed to the Random Positioning Machine.
Bauer J; Kopp S; Schlagberger EM; Grosse J; Sahana J; Riwaldt S; Wehland M; Luetzenberg R; Infanger M; Grimm D
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273809
[TBL] [Abstract][Full Text] [Related]
4. Mannich bases in medicinal chemistry and drug design.
Roman G
Eur J Med Chem; 2015 Jan; 89():743-816. PubMed ID: 25462280
[TBL] [Abstract][Full Text] [Related]
5. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB.
Matteucci C; Minutolo A; Marino-Merlo F; Grelli S; Frezza C; Mastino A; Macchi B
Life Sci; 2015 Apr; 127():90-7. PubMed ID: 25744407
[TBL] [Abstract][Full Text] [Related]
8. [Azidothymidine inhibition of telomerase activity and proliferation of TJ905 human glioblastoma cells].
Liu J; Wang Q; Yu SZ; Zhao WJ; Sun CY; An TL; Wang LL; Chen XJ
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):183-8. PubMed ID: 19575855
[TBL] [Abstract][Full Text] [Related]
9. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
10. Azidothymidine is effective against human multiple myeloma: a new use for an old drug?
Pereira J; Levy D; Ruiz JL; Brocardo GA; Ferreira KA; Costa RO; Queiroz RG; Maria DA; Neto AE; Chamone DA; Bydlowski SP
Anticancer Agents Med Chem; 2013 Jan; 13(1):186-92. PubMed ID: 22931421
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
